Related Experiment Video
Updated: Mar 31, 2026
Destabilization of the Medial Meniscus and Cartilage Scratch Murine Model of Accelerated Osteoarthritis
Published on: July 6, 2022
Exploratory transcriptomic analysis of mouse articular cartilage in response to tissue inhibitor of metalloproteinase
Manuela Mengozzi1, Ben Towler2, Jordan Kwabiah1
1Clinical and Experimental Medicine, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
Introduction:
Tissue inhibitor of metalloproteinase 3 (TIMP-3) is a broad-spectrum inhibitor of matrix metalloproteinases (MMPs) and ADAM/ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family enzymes that regulate extracellular matrix (ECM) homeostasis. Because these enzymes play key roles in articular cartilage turnover, TIMP-3-mediated inhibition protects against cartilage degradation, a hallmark of osteoarthritis (OA), and has been explored as a therapeutic target. Nonetheless, unexpected detrimental effects of TIMP-3 on bone mass and structure have been reported in transgenic mice overexpressing TIMP-3 in cartilage. Mechanistically, TIMP-3 binds catabolic enzymes and blocks their active sites but also interacts with low-density lipoprotein receptor-related protein 1 (LRP-1) and sulfated proteoglycans in the ECM, processes that regulate its half-life through a balance between endocytosis and ECM retention and may influence cell signaling.
Methods:
We investigated whether TIMP-3 affects gene expression in ex vivo mouse articular cartilage explants under normoxia or physiological hypoxia (3% O2). Femoral head cartilage explants were treated with recombinant TIMP-3 and then processed for RNA sequencing (RNA-seq).
Results:
Hypoxia alone induced a strong transcriptional response, confirming the model's responsiveness, whereas TIMP-3 altered the expression of only a small subset of genes. RT-qPCR validation confirmed TIMP-3-mediated upregulation of inflammation-associated genes, including Saa3 under both oxygen conditions, and IL-17 signaling pathway genes (Il17b, Mmp3 and Lcn2) under normoxia, and downregulation of proliferative genes Pbk/Topk and Racgap1 under hypoxia. Hypoxia alone downregulated all these genes.
Discussion:
The distinct transcriptional effects observed under normoxia and hypoxia highlight the importance of accounting for oxygen tension in cartilage studies. Potential inflammation-associated gene expression responses to TIMP-3 should be considered in its therapeutic development for arthritic disease and may inform optimization of treatment strategies.
Insights
Tissue inhibitor of metalloproteinase 3 (TIMP-3) influences cartilage gene expression, upregulating inflammation and downregulating proliferation genes. Its effects vary significantly under different oxygen levels, impacting osteoarthritis therapeutic development.
Area of Science:
- Biochemistry
- Molecular Biology
- Osteoarthritis Research
Background:
- Tissue inhibitor of metalloproteinase 3 (TIMP-3) regulates extracellular matrix (ECM) homeostasis by inhibiting matrix metalloproteinases (MMPs) and ADAM/ADAMTS enzymes.
- TIMP-3 is explored as a therapeutic target for osteoarthritis (OA) due to its role in cartilage degradation, but detrimental effects on bone have been observed.
- TIMP-3 interacts with ECM components and cell surface receptors like LRP-1, influencing its stability and signaling.
Purpose of the Study:
- To investigate the effects of TIMP-3 on gene expression in ex vivo mouse articular cartilage explants.
- To determine how oxygen tension (normoxia vs. hypoxia) influences TIMP-3's transcriptional effects in cartilage.
Main Methods:
- Articular cartilage explants from mouse femoral heads were treated with recombinant TIMP-3.
- Gene expression analysis was performed using RNA sequencing (RNA-seq) under normoxic and hypoxic (3% O2) conditions.
- Quantitative real-time PCR (RT-qPCR) was used for validation of specific gene expression changes.
Main Results:
- Hypoxia alone induced a significant transcriptional response in cartilage.
- TIMP-3 modulated a small subset of genes, upregulating inflammation-associated genes (e.g., Saa3, IL-17 pathway genes) under both oxygen conditions.
- TIMP-3 downregulated proliferative genes (Pbk/Topk, Racgap1) under hypoxia, while hypoxia alone downregulated these genes.
Conclusions:
- Oxygen tension critically influences the transcriptional response of cartilage to TIMP-3.
- TIMP-3's induction of inflammation-associated genes warrants consideration in therapeutic strategies for OA.
- Understanding TIMP-3's context-dependent effects is crucial for optimizing its use in treating arthritic diseases.
